SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001178913-22-001759
Filing Date
2022-05-02
Accepted
2022-05-02 16:13:36
Documents
194
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 20-F zk2227651.htm   iXBRL 20-F 6912741
2 EXHIBIT 2.1 exhibit_2-1.htm EX-2.1 20053
3 EXHIBIT 12.1 exhibit_12-1.htm EX-12.1 7853
4 EXHIBIT 12.2 exhibit_12-2.htm EX-12.2 7710
5 EXHIBIT 13.1 exhibit_13-1.htm EX-13.1 5169
6 EXHIBIT 13.2 exhibit_13-2.htm EX-13.2 5191
7 EXHIBIT 15.1 exhibit_15-1.htm EX-15.1 5928
  Complete submission text file 0001178913-22-001759.txt   31666141

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE trib-20211231.xsd EX-101.SCH 230172
9 XBRL CALCULATION FILE trib-20211231_cal.xml EX-101.CAL 91171
10 XBRL DEFINITION FILE trib-20211231_def.xml EX-101.DEF 586593
11 XBRL LABEL FILE trib-20211231_lab.xml EX-101.LAB 1377559
12 XBRL PRESENTATION FILE trib-20211231_pre.xml EX-101.PRE 904084
188 EXTRACTED XBRL INSTANCE DOCUMENT zk2227651_htm.xml XML 9040246
Mailing Address 3 ROCK ROAD SANDYFORD INDUSTRIAL ESTATES DUBLIN IRELAND L2 18
Business Address IDA BUSINESS PARK, BRAY, CO WICKLOW IRELAND DUBLIN IRELAND L2 18 01135312955111
TRINITY BIOTECH PLC (Filer) CIK: 0000888721 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 000-22320 | Film No.: 22882091
SIC: 2835 In Vitro & In Vivo Diagnostic Substances